3 High Quality Value Stocks For Investors Worried About Record High U.S. Indexes

Stock indexes near record highs, cautious sentiment, and warnings from Warren Buffett about “swimming naked when the tide goes out” create a tricky moment for anyone picking stocks. Frothy prices can punish weak businesses fast. Quality companies with solid balance sheets and reasonable valuations can sometimes turn that fear into opportunity. This article highlights 3 stocks from our High-Quality Value Stocks in Major U.S. Indexes screener that appear well placed against this backdrop.

Below are just a few examples from this idea. The full screen surfaced 24 more larger U.S. companies with similar value, balance sheet, and performance filters that are not covered here but carry their own detailed narratives. To see the broader opportunity set in one place, head straight to the High-Quality Value Stocks in Major U.S. Indexes screener to identify, filter, and analyze the highest conviction fits for your watchlist.

Cummins (CMI)

Cummins fits the High-Quality Value Stocks in Major U.S. Indexes theme as a large, profitable industrial player with steady dividends and a solid balance sheet. Its push into power and data-center projects is what really gets investors’ attention right now.

Cummins generates about US$10.9b from its Engine unit, US$10.2b from Components, US$12.9b from Distribution, US$8.1b from Power Systems, and US$0.5b from Accelera, and with a market value around US$72.3b it is firmly in large-cap territory.

"Cummins is investing $200 million in its manufacturing sites in the U.S., England, and India to increase power generation capacity, which is expected to drive strong revenue growth, particularly in the data center market."

What happens to Cummins’ earnings profile if one pressure on future power-system profitability moves in the right direction or the wrong one?

If that profit swing is what you are watching, the full narrative for Cummins lays out how Cummins’ power buildout, contracts, and risks could reshape its earnings mix.

Intuit (INTU)

Intuit underpins a large slice of everyday money management and tax filing for households and small businesses, which fits neatly with a screener focused on bigger, profitable U.S. companies offering durable cash flows rather than fragile hype stories.

Intuit runs two main operations, Global Business Solutions and Consumer, with the former generating about US$12.9b in sales and the latter about US$8.6b, and the stock is valued around US$73.7b.

"Intuit is now trying to close that exit door. On top of that, Intuit has struck a multi-year partnership with Anthropic to embed what they are calling "Agentic AI" directly into the platform."

What happens to Intuit’s long-run earnings power if one quiet shift in how customers adopt and pay for these AI-driven tools breaks in either direction?

If that adoption curve is what you care about, full narrative for Intuit illustrates how Intuit’s Agentic AI initiatives could accelerate monetization while reshaping risk for long term holders.

Stryker (SYK)

Stryker is a large medical technology group that fits this high-quality value screen because it blends scale, recurring hospital demand, and resilient margins in a sector where patients still need treatment even when markets cool.

Stryker develops surgical, neurotechnology and orthopaedic products worldwide, generating about US$9.7b from Orthopaedics and US$16.1b from MedSurg and Neurotechnology, and the stock carries a market value near US$104.5b.

For investors worried about stretched indexes but still wanting exposure to long term healthcare demand, Stryker offers a mix of robotics, capital equipment, and procedure-linked products that tie directly into hospitals’ need to treat more complex cases efficiently.

"Expanding use of Stryker’s Mako platform, including record installations, broader procedure coverage such as shoulder and advanced hip or revision, and the rollout of Mako RPS for handheld knee robotics, supports a larger orthopedic addressable market and can lift revenue and associated service earnings over time."

The key question now is how one quiet shift in hospital spending priorities and product mix ends up shaping Stryker’s margin path.

As that spending mix evolves, the full narrative for Stryker shows how Stryker’s robotics push, capital cycles and hospital budgets could be quietly accelerating an earnings mix shift investors are underestimating.

Seeking Alternatives Before Others Catch On

Fresh ideas do not stay under the radar for long. Once momentum builds, ideal entry points can be harder to find. Scan these curated lists while it matters and consider your options.

• Identify resilient cash generators early by reviewing the 30 resilient stocks with low risk scores that could help cushion your portfolio if momentum drops elsewhere.
• Explore potential infrastructure opportunities by checking the 40 power grid technology and infrastructure stocks that may benefit as grids modernize and capital is allocated to critical upgrades.
• Evaluate developments in automation by assessing the 92 robotics and automation stocks that may be positioned to respond to demand for efficiency and precision.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com